Molecular Reagent Xpert® C. Difficile 10 Tests

Features

• The alarming rise in the incidence of Clostridium difficile infection (CDI) highlights the need for rapid and accurate diagnostic solutions Sensitivity of current available rapid diagnostic tests are unacceptably low Additional length of stay increase caused by C. difficile infection is 5.6 days Incremental costs due to C. difficile infection can be as high as $7
• 1791 per patient Management of CDI requires rapid and accurate diagnosis Cepheid’s Xpert C. difficile delivers both while enabling clinicians to optimize patient management and reduce length of stay